Tyra Biosciences, Inc. (TYRA)
38.18
+0.13
(+0.34%)
USD |
NASDAQ |
Mar 19, 16:00
38.16
-0.02
(-0.05%)
After-Hours: 20:00
Tyra Biosciences Total Assets (Quarterly) : 284.05M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 777.78M |
| Agios Pharmaceuticals, Inc. | 1.297B |
| BridgeBio Pharma, Inc. | 936.02M |
| Nuvalent, Inc. | 1.413B |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 24.87M |
| Shareholders Equity (Quarterly) | 259.18M |
| Debt to Equity Ratio | 0.0224 |
| Current Ratio | 14.67 |
| Net Debt Paydown Yield | 0.01% |